Economy

UniQure NV - Ordinary Shares (NASDAQ:QURE) Moving Aggressively - Up $0.06

UniQure NV - Ordinary Shares (NASDAQ:QURE) Moving Aggressively - Up $0.06”

uniQure N.V. (NASDAQ:QURE) shares typically trade an average volume of 283.09 and institutions hold 59.90% of the total shares. The company presently has an average rating of "Hold" and a consensus target price of $12.45. The Company?s product candidates include AMT-060 for Hemophilia B, AMT-130 for Huntington's disease, S100A1 for congestive heart failure and Glybera for lipoprotein lipase deficiency (LPLD). uniQure has established clinical proof-of-concept in its lead indication, hemophilia B and has achieved pre-clinical, proof-of-concept in Huntington's disease.

Additionally, according to TipRanks, cautious optimism is circling the biotech firm when looking at Wall Street sentiment, considering that based on 6 analysts polled in the 12 months, half rate a Buy on Uniqure stock while half maintain a Hold. UNIQURE B.V.is headquartered in Amsterdam, the Netherlands. The stock was trading at a distance of -0.87% from its 52-week highs and stands 57.42% away from its 52-week lows. These are called exhaustion moves because typically when so many shares change hands there is no one left to keep pushing the price in the trending direction and it reverses (often quickly). The company now has an average rating of "Hold" and an average target price of $13.54. The analysts estimated EPS for the higher end at -0.48 and lower end at -0.73 while the year ago reported earnings per share was -0.98. The business had revenue of $4.94 million during the quarter, compared to analyst estimates of $2.92 million. The company's market cap is $194.75 million.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by Week Herald and is owned by of Week Herald. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & global trademark and copyright law. The stock's quarterly performance indicates a positive momentum of 14.37 percent, whereas its last one month trend is optimistic with 16.05 percent. Renaissance Technologies LLC now owns 374,000 shares of the biotechnology company's stock worth $2,162,000 after buying an additional 122,700 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of uniQure N.V.by 50.5% during the 1st quarter. FMR LLC grew its stake in uniQure N.V.by 4.1% in the 2nd quarter.

The company's diluted EPS for trailing twelve months was -3.01. Finally, Renaissance Technologies LLC lifted its holdings in shares of uniQure N.V.by 48.8% during the 1st quarter.

Investors of this company earned a return of -41.90% on the assets it owns in past twelve month.

Now we take a performance look how uniQure N.V. (QURE) has been performing in different time periods. The Company is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. The Company is advancing a focused pipeline of gene therapies that have been developed both internally and through partnerships.



Like this

Latest


21 October 2017
Rio 2016 leader Nuzman to be released from jail
After his arrest, Nuzman resigned from his position as COB President, where he was serving his sixth consecutive term. Brazil's Superior Tribunal of Justice ruled that Nuzman's arrest was not proportional to the charges he faced.

21 October 2017
Dallas Cowboys VS San Francisco 49ers matchup preview
Beathard likes to get outside the pocket so it will be the job of the Dallas ends to play contain and corral the passer on Sunday. The Cowboys will need that strong showing in a game that can be viewed as something close to a must-win. 49ers' quarterback C.J.

21 October 2017
McCain demands answers on deadly Niger attack
McCain and others urged the agencies to develop a comprehensive plan before Russian Federation strikes again. Most of the Armed Services committee did not like what they heard.

21 October 2017
Cwm, LLC Increases Its Investment in Range Resources Corporation (RRC) Stock
The stock is now moving below its 20-Day Simple Moving Average of -3.58% with a 50-Day Simple Moving Average of 2.25 percent. Whereas, in last 21 trading days (one month) was moved up 1.62% and slashed in last 63 trading days (quarter) of -13.86%.

21 October 2017
U.S. says 24 people harmed from recent 'attacks' in Cuba
They began in staffers' homes in Havana, but the AP disclosed in September that they later occurred in hotels as well. She says the additional victims were confirmed following medical evaluations of workers attacked earlier in the year.

21 October 2017
Berenberg Bank Cuts Unilever plc (ULVR) Price Target to GBX 5000
Unilever plc (LON:ULVR)'s stock had its "hold" rating reissued by Whitman Howard in a research report issued on Thursday. The stock of Spectra Energy Partners, LP (NYSE:SEP) earned "Neutral" rating by Credit Suisse on Thursday, March 17.

21 October 2017
Nawaz Sharif schedule to return to Pakistan changed
She said this is the first case of its kind in which the verdict has been announced first and the trial is being held later. He is scheduled to fly back to Pakistan next week to face the court cases and has no plan to stay overseas .

21 October 2017
The Goodyear Tire & Rubber Company (GT) Consensus Earnings Outlook
Rather than make assumptions, investors should carefully read the definitions of all ratings used in each research report. Investors and traders may use this indicator to help spot price reversals, price extremes, and the strength of a trend.

21 October 2017
Strictly's Bruno Tonioli will MISS this weekends show
After the judges have given their scores, the public will have the chance to cast their votes. More: Could Brendan Cole Be About To Quit Strictly Come Dancing?

21 October 2017
Gov. Cuomo signs bill to protect circus elephants in NY
"The use of elephants in these types of settings is unsafe to their health and potentially abusive", Governor Cuomo said. New Yorkers have proved that they don't want to see sensitive and complex elephants chained and beaten for circus shows.



Recommended